These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6420304)

  • 1. A [14C]phenacetin breath test to measure hepatic function in man.
    Breen KJ; Bury RW; Calder IV; Desmond PV; Peters M; Mashford ML
    Hepatology; 1984; 4(1):47-52. PubMed ID: 6420304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CO2 breath tests using 14C-caffeine, 14C-methacetin and 14C-phenacetin for assessing postnatal development of monooxygenase activities in rats and marmosets.
    Krüger N; Helge H; Neubert D
    Dev Pharmacol Ther; 1991; 16(3):164-75. PubMed ID: 1914790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of drug metabolism in hepatic disease: comparison of plasma kinetics of oral cyclobarbital and the intravenous aminopyrine breath test.
    Breyer-Pfaff U; Seyfert H; Weber M; Egberts EH
    Eur J Clin Pharmacol; 1984; 26(1):95-101. PubMed ID: 6143671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminopyrine disposition: studies on breath, saliva, and urine of normal subjects and patients with liver disease.
    Hepner GW; Vesell ES
    Clin Pharmacol Ther; 1976 Dec; 20(6):654-60. PubMed ID: 991536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the phenacetin and aminopyrine breath tests: effect of liver disease, inducers and cobaltous chloride.
    Schoeller DA; Kotake AN; Lambert GH; Krager PS; Baker AL
    Hepatology; 1985; 5(2):276-81. PubMed ID: 3920135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of hepatic function by breath analysis after oral administration of (14C)aminopyrine.
    Hepner GW; Vesell ES
    Ann Intern Med; 1975 Nov; 83(5):632-8. PubMed ID: 1200495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of breath analysis in diagnosis of liver function (author's transl)].
    Caspary WF
    Z Gastroenterol; 1978 Mar; 16(3):188-97. PubMed ID: 636512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.
    Fasoli A; Giannini E; Botta F; Romagnoli P; Risso D; Celle G; Testa R
    Hepatogastroenterology; 2000; 47(31):234-8. PubMed ID: 10690614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminopyrine demethylation measured by breath analysis in cirrhosis.
    Bircher J; Küpfer A; Gikalov I; Preisig R
    Clin Pharmacol Ther; 1976 Oct; 20(4):484-92. PubMed ID: 975720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine: a model compound for measuring liver function.
    Renner E; Wietholtz H; Huguenin P; Arnaud MJ; Preisig R
    Hepatology; 1984; 4(1):38-46. PubMed ID: 6420303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Output of 14CO2 in breath after oral administration of (14C-methyl) aminopyrine in hepatitis, cirrhosis and hepatic bilharziasis: its relationship to aminopyrine pharmacokinetics.
    Noordhoek J; Dees J; Savenije-Chapel EM; Wilson JH
    Eur J Clin Pharmacol; 1978 May; 13(3):223-9. PubMed ID: 668778
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of the cytochrome P-448 dependent liver enzyme system by a caffeine breath test.
    Wietholtz H; Voegelin M; Arnaud MJ; Bircher J; Preisig R
    Eur J Clin Pharmacol; 1981; 21(1):53-9. PubMed ID: 6800827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between aminopyrine breath test and severity of liver disease in cirrhosis.
    Morelli A; Narducci F; Pelli MA; Farroni F; Vedovelli A
    Am J Gastroenterol; 1981 Aug; 76(2):110-3. PubMed ID: 6795921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired clearance of phenacetin in hepatic cirrhosis and fibrosis.
    Qu ZQ; Li XD; Liu HL; He P; Zhang X; Wu MC
    Int J Clin Pharmacol Ther; 2007 Jan; 45(1):55-62. PubMed ID: 17256451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel variant of the
    Holzhütter HG; Wuensch T; Gajowski R; Berndt N; Bulik S; Meierhofer D; Stockmann M
    Arch Toxicol; 2020 Feb; 94(2):401-415. PubMed ID: 32020249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple method for routine determination of the metabolic liver capacity: the aminopyrine breath test.
    Haustein KO; Schenker E
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):190-6. PubMed ID: 3922902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of liver function by the aminopyrine breath test.
    Villeneuve JP; Arsène D; Huet PM
    Clin Invest Med; 1983; 6(1):5-9. PubMed ID: 6403268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Test for alcoholic cirrhosis by conversion of [14C]- or [13C]galactose to expired CO2.
    Shreeve WW; Shoop JD; Ott DG; McInteer BB
    Gastroenterology; 1976 Jul; 71(1):98-101. PubMed ID: 1278655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesteryl octanoate breath test. Preliminary studies on a new noninvasive test of human pancreatic exocrine function.
    Cole SG; Rossi S; Stern A; Hofmann AF
    Gastroenterology; 1987 Dec; 93(6):1372-80. PubMed ID: 3678753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breath 14CO2 after intravenous administration of [14C]aminopyrine in liver diseases.
    Pauwels S; Geubel AP; Dive C; Beckers C
    Dig Dis Sci; 1982 Jan; 27(1):49-56. PubMed ID: 6802621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.